spoke to management this week and last. There was an erroneous report outlast week (since been withdrawn)on linking Omega 3 intake with increased prostate cancer. as stated it was withdrawn after scientists from reputable organizations such as the World Health Organization and Heart Foundation strongly criticized the lack of science methodology behind the study.
http://omega3.supplysideinsights.com/articles/2013/07/media-hype-on-omega-3s-and-prostate-cancer-misrep.aspx
Clover state that all is good in terms of sales targets and forecasts given to the market
spoke to management this week and last. There was an erroneous...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CLV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
-0.005(1.01%) |
Mkt cap ! $60.11M | |||
| Open | High | Low | Value | Volume |
| 49.0¢ | 49.5¢ | 49.0¢ | $8.983K | 18.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32789 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 44797 | 1 |
View Market Depth
| Last trade - 15.45pm 15/11/2024 (20 minute delay) ? |
| CLV (ASX) Chart |
